Image

Global Epigenetics Market – Industry Trends and Forecast to 2030

Healthcare

Image

Global Epigenetics Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Oct 2023
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Epigenetics Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 13.17 Billion
Diagram Market Size (Forecast Year) USD 57.40 Billion
Diagram CAGR %

Major Markets Players

  • Illumina
  • Merck
  • QIAGEN
  • F. HoffmannLa Roche
  • Eisai

Global Epigenetics Market, By Product (Enzymes, Instruments and Consumables, Kits, Reagents), Application (Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Others), Technology (DNA Methylation, Histone Methylation, Others), End User (Academic and Research Institutes, Pharmaceutical Companies and Biotechnology Companies, Contract Research Organizations (CROs)) – Industry Trends and Forecast to 2030.

Epigenetics Market

Epigenetics Market Analysis and Size

Epigenetic mechanisms are being linked to an increasing number of chronic diseases and disorders, such as cardiovascular disease, autoimmune disease, and neurodegenerative disorders, and environmental factors and nutritional imbalance, all of which have a significant impact on epigenetic processes such as DNA methylation, histone modification, and non-coding RNA.

Data Bridge Market Research analyzes that the global epigenetics market which was USD 13.17 billion in 2022, would rocket up to USD 57.40 billion by 2030, and is expected to undergo a CAGR of 20.20% during the forecast period. The “Enzymes” segment is expected to dominate the product segment of the market owing to the rise in cancer prevalence rate worldwide.

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Epigenetics Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Product (Enzymes, Instruments and Consumables, Kits, Reagents), Application (Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Others), Technology (DNA Methylation, Histone Methylation, Others), End User (Academic and Research Institutes, Pharmaceutical Companies and Biotechnology Companies, Contract Research Organizations (CROs))

Countries Covered

U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America

Market Players Covered

Illumina, Inc. (U.S.), Merck KGaA (Germany), QIAGEN (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Eisai Co., Ltd. (Japan), Novartis AG (Switzerland), Abcam plc (U.K.), Diagenode s.a. (U.S.), Active Motif, Inc. (U.S.), Zymo Research Corporation. (U.S.), Thermo Fisher Scientific (U.S.), Cellcentric (Germany), Syndax (U.S.), New England Biolabs (U.S.), Epizyme, Inc. (U.S.), Domainex (U.K.), Agilent Technologies, Inc. (U.S.), PerkinElmer Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), AsisChem Inc. (U.S.), Enzo Life Sciences, Inc. (U.S.), EpiGentek Group Inc. (U.S.), BioVision Inc. (U.S.), Bio-Techne. (U.S.), Promega Corporation (U.S.), GeneTex, Inc. (U.S.), and Pacific Biosciences of California, Inc. (U.S.)

Market Opportunities

  • The decrease in sequencing costs and time
  • The increase in research activities
  • The accessibility of government funding

Market Definition

Epigenetics is a branch of genetics concerned with the study of cellular and physiological trait variations caused by environmental or ecological factors that turn genes on and off and influence the cellular ability to read genes without being affected by genotype changes. It causes changes in an organism's phenotype rather than genotype, with the underlying DNA or RNA sequence remaining constant.

Global Epigenetics Market Dynamics

Drivers

  • Increasing Cancer Research

Epigenetics plays a crucial role in the development and progression of cancer. There is a growing emphasis on understanding the epigenetic modifications associated with different types of cancer as cancer research continues to advance. This drives demand for epigenetic analysis tools and technologies, including DNA methylation and histone modification assays.

  • Rising Prevalence of Chronic Diseases

Chronic diseases such as diabetes, cardiovascular diseases, and neurological disorders have been linked to epigenetic changes. With the increasing global burden of these diseases, there is a growing need for epigenetic research to identify potential biomarkers and therapeutic targets, which contributes to market growth.

  • Personalized Medicine and Drug Development

Epigenetic profiling allows for personalized medicine approaches, where treatments and therapies can be tailored to an individual's unique epigenetic profile. This has gained importance in the development of targeted therapies and drug discovery, thereby driving the adoption of epigenetic technologies by pharmaceutical and biotechnology companies.

  • Technological Advancements

Ongoing advancements in epigenetic research tools and technologies, including next-generation sequencing, DNA methylation arrays, and epigenome editing techniques, have made epigenetic analysis more accessible and cost-effective. These technological innovations have expanded the capabilities of researchers and healthcare professionals, further fueling the market growth.

Opportunities

  • Precision Medicine Advancements

Epigenetics has the potential to revolutionize the field of precision medicine. There is a significant opportunity to develop personalized treatment strategies based on a patient's epigenetic profile as our understanding of epigenetic modifications and their role in disease increases. This could lead to more effective and targeted therapies for various diseases, including cancer and neurological disorders.

  • Biomarker Discovery

Epigenetic markers can serve as valuable biomarkers for various diseases. Identifying and validating epigenetic biomarkers for early disease detection, disease prognosis, and treatment response monitoring can create new opportunities for diagnostic and prognostic tests. These tests can aid in early intervention and personalized patient care.

Restraints

  • Limited Understanding of Epigenetic Mechanisms

The complexity of epigenetic mechanisms and their role in various diseases is not yet fully understood. This limited understanding can hinder the development of targeted therapies and diagnostics, and the identification of reliable epigenetic biomarkers.

  • High Costs of Tools

Many epigenetic analysis techniques and tools can be expensive, which can make them less accessible to researchers and healthcare providers with limited budgets. The high cost of equipment, reagents, and data analysis tools can be a significant barrier to entry and adoption.

Challenges

  • Data Complexity and Interpretation

Epigenetic data is inherently complex, often involving large datasets with numerous layers of information. Analyzing and interpreting this data can be challenging, requiring advanced bioinformatics and computational tools. Researchers and clinicians need to overcome these challenges to translate epigenetic findings into actionable insights.

  • Standardization and Quality Control

Ensuring the quality and consistency of epigenetic data and assays is crucial for reliable research and clinical applications. Standardization of epigenetic protocols, assays, and data analysis procedures is a challenge, as variations in techniques and platforms can lead to discrepancies and difficulties in comparing results across studies.

The global epigenetics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, and technological innovations in the market. To gain more info on this market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you make an informed market decision to achieve market growth.

Recent Development

  • In February 2022, Zenith Epigenetics Ltd. reported the dosing of the first patient with a combination of ZEN-3694 (BET inhibitor) + Bristol Myers Squibb’s PD-1 immune checkpoint inhibitor OPDIVO and YERVOY in a National Cancer Institute (NCI), part of the National Institutes of Health, sponsored trial in solid tumor cancer
  • In February 2022, Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, entered a partnership with Dovetail Genomics to demonstrate the value and performance of Dovetail’s proximity ligation-based-based next-generation sequencing (NGS) library prep solutions on Element’s AVITI System

Global Epigenetics Market Scope

The global epigenetics market is segmented on the basis of product, application, technology, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Enzymes
  • DNA-modifying enzymes
  • Protein-modifying enzymes
  • RNA-modifying enzymes
  • Instruments and Consumables
  • Next-generation sequencers
  • qPCR, mass spectrometers
  • Sonicators
  • Others
  • Kits
  • Bisulfite conversion kits
  • ChIP-sequencing kits
  • RNA sequencing kits
  • whole genomic amplification kits
  • 5-hmC and 5-mC analysis kits
  • Others
  • Reagents
  • Antibodies
  • Buffers
  • Histones
  • Magnetic beads
  • Primers
  • Others

Application

  • Oncology
  • Metabolic Diseases
  • Developmental Biology
  • Immunology
  • Cardiovascular Diseases
  • Others

Technology

  • DNA Methylation
  • Histone Methylation
  • Others

End User

  • Academic and Research Institutes
  • Pharmaceutical Companies and Biotechnology Companies
  • Contract Research Organizations (CROs)

 Global Epigenetics Market Regional Analysis/Insights

The global epigenetics market is analyzed and market size insights and trends are provided by country, product, application, technology, and end user as referenced above.

The countries covered in this market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.

North America is expected to dominate the global epigenetics market due to the growing research activities on epigenetics. Furthermore, the presence of innovative healthcare amenities that are provided and continuous developments in the diagnostic process are expected to further boost market growth in the region during the forecast period.

Asia-Pacific is expected to be the fastest-growing region in the market due to the rise in disposable income. Moreover, the growing untapped clinical needs of the patients are further expected to drive market growth in the region.

The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as downstream and upstream value chain analysis, technical trends, Porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data. 

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global epigenetics market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the market. The data is available for the historic period 2011-2021.

Competitive Landscape and Global Epigenetics Market Share Analysis

The global epigenetics market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major players operating in the global epigenetics market are:

  • Bio-Techne. (U.S.)
  • Promega Corporation (U.S.)
  • GeneTex, Inc. (U.S.)
  • Pacific Biosciences of California, Inc. (U.S.)
  • Illumina, Inc. (U.S.)
  • Merck KGaA (Germany)
  • QIAGEN (Germany)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Eisai Co., Ltd. (Japan)
  • Novartis AG (Switzerland)
  • Abcam plc (U.K.)
  • Diagenode s.a. (U.S.)
  • Active Motif, Inc. (U.S.)
  • Zymo Research Corporation. (U.S.)
  • Thermo Fisher Scientific (U.S.)
  • Cellcentric (Germany)
  • Syndax (U.S.)
  • New England Biolabs (U.S.)
  • Epizyme, Inc. (U.S.)
  • Domainex (U.K.)
  • Agilent Technologies, Inc. (U.S.)
  • PerkinElmer Inc. (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • AsisChem Inc. (U.S.)
  • Enzo Life Sciences, Inc. (U.S.)
  • EpiGentek Group Inc. (U.S.)
  • BioVision Inc. (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The epigenetics market size will be worth USD 57.40 billion by 2030 during the forecast period.
The growth rate of the epigenetics market is 20.20% in the forecast period by 2030.
The Increasing cancer research, rising prevalence of chronic diseases & personalized medicine, and drug development are the growth drivers of the epigenetics market.
The Product, application, technology, and end user are the factors on which the epigenetics market research is based.
Major companies in the epigenetics market are Illumina, Inc. (U.S.), Merck KGaA (Germany), QIAGEN (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Eisai Co., Ltd. (Japan), Novartis AG (Switzerland), Abcam plc (U.K.), Diagenode s.a. (U.S.), Active Motif, Inc. (U.S.), Zymo Research Corporation. (U.S.), Thermo Fisher Scientific (U.S.), Cellcentric (Germany), Syndax (U.S.), New England Biolabs (U.S.), Epizyme, Inc. (U.S.), Domainex (U.K.), Agilent Technologies, Inc. (U.S.), PerkinElmer Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), AsisChem Inc. (U.S.), Enzo Life Sciences, Inc. (U.S.), EpiGentek Group Inc. (U.S.), BioVision Inc. (U.S.), Bio-Techne. (U.S.), Promega Corporation (U.S.), GeneTex, Inc. (U.S.), and Pacific Biosciences of California, Inc. (U.S.).
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials